Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result | |
Cai, Shaohang; Yu, Tao; Jiang, Yegui; Zhang, Yonghong; Lv, Fangfang; Peng, Jie* | |
刊名 | Clinical and Experimental Medicine
![]() |
2016 | |
卷号 | 16期号:3页码:429-436 |
关键词 | Chronic hepatitis B High viral load Nucleos(t)ide analogs Virologic response |
ISSN号 | 1591-8890 |
DOI | 10.1007/s10238-015-0373-2 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000380668500022 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3318293 |
专题 | 中南大学 |
作者单位 | 1.[Peng, Jie 2.Cai, Shaohang 3.Yu, Tao] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China. |
推荐引用方式 GB/T 7714 | Cai, Shaohang,Yu, Tao,Jiang, Yegui,et al. Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result[J]. Clinical and Experimental Medicine,2016,16(3):429-436. |
APA | Cai, Shaohang,Yu, Tao,Jiang, Yegui,Zhang, Yonghong,Lv, Fangfang,&Peng, Jie*.(2016).Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.Clinical and Experimental Medicine,16(3),429-436. |
MLA | Cai, Shaohang,et al."Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result".Clinical and Experimental Medicine 16.3(2016):429-436. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论